Skip to main content

Forum
Career Center
Cart
My Account
Logout

Main navigation

Membership
Education
PALTC Profession
Resources
Advocacy
Publications
About

Breadcrumb

Home / News and Media / Neuroleptic Malignant Syndrome Due to Dopamine Agonist Withdrawal: A Reminder About the Dangers of NPO Status

Neuroleptic Malignant Syndrome Due to Dopamine Agonist Withdrawal: A Reminder About the Dangers of NPO Status

JAMDA

February 25, 2016

PALTtalk Ad

Advertisement

Advertisement

Latest News

View All

Policy Snapshot

September 13, 2024

PALTmed Submits Comments on 2025 Physician Fee Schedule

Policy Snapshot

September 13, 2024

Review Your 2023 MIPS Final Scores

Spotlight

September 13, 2024

Updated Diabetes CPG: Team Tool for Today’s PALTC

Podcast

September 11, 2024

PALTtalk Special Edition: Pain Management for Patients with Substance Use Disorder | A Collaboration with the Center of Excellence for Behavioral Health in Nursing Facilities

Contact Us

9891 Broken Land Parkway
Suite 101
Columbia, MD 21046
410-740-9743

Helpful Links

About
Annual Conference
Policy & Advocacy
Membership
Forum
Career Center
FAQ
Certification
Foundation for PALTC Medicine
Corporate Partners

Twitter
Instagram
LinkedIn

© 2025 All Rights Reserved. | Privacy Policy